ARCHIVES

How NCI’s Plans For Software Giveaway Sank In Scientific And Legal Disputes (Part Two In A Series About NCI’s Bioinformatics Venture caBIG).

This article is from The Cancer Letter archive.

Vol. 37 No. 09 | March 4, 2011

Download PDF Visit The Full Archive

Related Articles

FDA Official Outlines agency’s Views On Efficacy Requirement

June 16, 1999

Curt, Ozols, Brown Leaving NCI; More DCT Staff Changes

June 10, 1988

Decisively Positive Swedish Study of PSA Becomes Focus of Debate Over Screening

October 28, 2011

Chemoprevention Clinical Trials To starts In 1982 If Greenwald, DRCCA Board Can Move Fast Enough

August 28, 1981

Progression-free survival as a primary endpoint for drug approval requires prospective planning, FDA’s Pazdur says.

May 7, 2004

Aranesp Study Finds No Difference In Survival Or Progression In Small-Cell Lung Cancer.

April 20, 2007